Synthesis and Anti-Hepatitis B Virus Evaluation of Novel Ethyl 6-Hydroxyquinoline-3-carboxylates in Vitro

Yajing Liu,Yanfang Zhao,Xin Zhai,Xusheng Feng,Jinxin Wang,Ping Gong

DOI: https://doi.org/10.1016/j.bmc.2008.05.029

IF: 3.461

2008-01-01

Bioorganic & Medicinal Chemistry

Abstract:A series of non-nucleoside ethyl 6-hydroxyquinoline-3-carboxylate derivatives were prepared and evaluated in HepG2.2.15 cells. Most compounds inhibited the expression of viral antigens HBsAg or HBeAg at low concentration. Six compounds, 9f(3), 12b(6), 12f(6), 13b(2), 13b(6), and 13f(6), displayed excellent intracellular inhibitory activity and selectivity towards the replication of HBV DNA. Of these six initial hits, compound 13b(6) was the most active.